`
`
`
`
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`
`Celltrion, Inc., Petitioner,
`
`
`
`v.
`
`Genentech, Inc.
`Patent Owner
`
`
`Case IPR2017-01374
`Patent 6,407,213
`
`DECLARATION OF ROBERT V. CERWINSKI IN SUPPORT OF
`MOTION FOR PRO HAC VICE ADMISSION
`
`Mail Stop PATENT BOARD
`Patent Trial and Appeal Board
`United States Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Celltrion, Inc. v. Genentech, Inc.
`IPR2017-01374
`
`1 of 4
`
`Celltrion, Inc., Exhibit 1137
`
`
`
`
`
`1.
`
`I, Robert V. Cerwinski, am more than twenty-one years of age, am
`
`competent to present this affidavit, and have personal knowledge of the facts set
`
`forth herein.
`
`2.
`
`This affidavit is given in support of Petitioner’s Motion for my Pro
`
`Hac Vice Admission.
`
`3.
`
`4.
`
`I am a partner with the law firm of Goodwin Procter LLP.
`
`I am an experienced litigation attorney. I have been practicing law
`
`since 1997 and have extensive experience litigating patent infringement cases in
`
`many different courts across the United States.
`
`5. My experience in patent litigation matters includes patent bench and
`
`jury trials, patent summary judgment proceedings, and other patent-related hearings
`
`and pleadings concerning, inter alia, patent validity and infringement issues. I have
`
`also represented clients’ appeals before the Court of Appeals for the Federal Circuit
`
`resulting from cases I tried and in other cases.
`
`6.
`
`I have an established familiarity with the subject matter at issue in this
`
`proceeding. I have reviewed the Petition and accompanying exhibits filed in this
`
`proceeding and all other papers associated with this proceeding, and have studied
`
`the ’213 patent. Additionally, I am involved with other IPRs on behalf of
`
`Celltrion, which pertain to related subject matter, including IPR2017-01373,
`
`
`
`
`
`
`
`
`Celltrion, Inc. v. Genentech, Inc.
`IPR2017-01374
`
`2 of 4
`
`Celltrion, Inc., Exhibit 1137
`
`
`
`
`
`IPR2017-01121, IPR2017-01122, IPR2017-01139, IPR2017-01140, and
`
`IPR2017-00959 (which is now terminated).
`
`7.
`
`I am a member in good standing of the Bar of the State of New York
`
`and am admitted to practice before the United States District Court for the Southern
`
`District of New York and the United States Court of Appeals for the Federal
`
`Circuit.
`
`8.
`
`I have never been suspended or disbarred from practice before any
`
`court or administrative body.
`
`9.
`
`No application of mine for admission to practice before any court or
`
`administrative body has ever been denied.
`
`10. No sanctions or contempt citations have been imposed against me by
`
`any court or administrative body.
`
`11.
`
`I have read and will comply with the Office Patent Trial Practice
`
`Guide and the Board’s Rules of Practice for Trials set forth in part 42 of 37 C.F.R.
`
`12.
`
`I understand that I will be subject to the USPTO Code of Professional
`
`Conduct set forth in 37 C.F.R.§§ 11.101 et seq. and disciplinary jurisdiction under
`
`37 C.F.R. §11.19(a).
`
`13.
`
`I have applied to appear pro hac vice in the following proceedings
`
`before the Office in the last three years: IPR2015-01566 (granted), IPR2015-01571
`
`(action terminated before ruling), IPR2015-01572 (action terminated before ruling),
`
`
`
`2
`
`Celltrion, Inc. v. Genentech, Inc.
`IPR2017-01374
`
`3 of 4
`
`Celltrion, Inc., Exhibit 1137
`
`
`
`
`
`IPR2015-01570 (action terminated before ruling), IPR2015-01733 (action
`
`terminated before ruling), IPR2015-01744 (action terminated before ruling),
`
`IPR2016-01614 (granted), IPR2016-01667 (action terminated before ruling),
`
`IPR2017-01121 (pending), IPR2017-01122 (pending), IPR2017-01139 (pending),
`
`and IPR2017-01140 (pending).
`
` hereby declare under penalty of perjury under the laws of the United States of America
`
` I
`
`that the foregoing is true and correct to the best of my knowledge.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Dated: January 9, 2018
`
`
`
`GOODWIN PROCTER LLP
`
`
`
`3
`
`Celltrion, Inc. v. Genentech, Inc.
`IPR2017-01374
`
`4 of 4
`
`Celltrion, Inc., Exhibit 1137
`
`